Conor McClenaghan is an Assistant Professor in the Dept. of Pharmacology and the Dept. of Medicine at Robert Wood Johnson Medical School, and a resident faculty member at the Center for Advanced Biotechnology and Medicine. He trained as a postdoc at Washington University in St Louis with Colin Nichols, where research focused on molecular dysfunction and cardiovascular pathophysiology in genetic diseases arising from mutations in ATP-sensitive potassium (KATP) channels. Prior to this, he received a Ph.D. from the University of Oxford, UK, where he studied the structure and function of the TREK subfamily of K2P potassium channels which are integral to temperature and touch sensation, and critical determinants of pain sensing. Research in the McClenaghan lab focuses on the molecular function of ion channels, mechanism of action of ion channel modulating drugs, and the consequences of dysfunctional electrical signaling in human disease.
You can learn more by watching Conversations with CABM Director: An interview with Dr. Conor McClenaghan